A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) Malaria
Clinical trial NCT02563496 · COMPLETED
Trial details
- NCT number
- NCT02563496
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-06
- Primary completion
- 2019-12-15
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.